# AbCellera Biologics Inc.: Form 8-K, filed Aug 6, 2024

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2024-08-06
- Accepted by EDGAR: Aug 6, 2024, 16:26 ET
- Period: 2024-08-06
- Accession: 0001628280-24-035229
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000162828024035229/abcl-20240806.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000162828024035229/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000162828024035229/abcl-20240806.htm

Filed Aug 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-035229. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.